VITEK® 2 OPUS AST CARDSANTIBIOTIC SUSCEPTIBILITY TESTING

Giving clinicians more treatment options

01-1

8 /

9314

381/

002/

GB/

A /

Docu

men

t and

/or p

ictu

res

not l

egal

ly b

indi

ng. M

odifi

catio

ns b

y bi

oMér

ieux

can

be

mad

e w

ithou

t prio

r not

ice

/ BI

OM

ERIE

UX, t

he B

IOM

ERIE

UX lo

go a

nd V

ITEK

are

use

d, p

endi

ng a

nd/o

r reg

iste

red

trad

emar

ks b

elon

ging

to

bioM

érie

ux, o

r one

of i

ts s

ubsi

diar

ies,

or o

ne o

f its

com

pani

es /

Any

oth

er n

ame

or tr

adem

ark

is th

e pr

oper

ty o

f its

resp

ectiv

e ow

ner /

bio

Mér

ieux

S.A

. 673

620

399

RCS

Lyo

n /

Phot

os: N

. Bou

chut

/ P

rinte

d in

Fra

nce

/ th

éra

RCS

Lyon

B 3

98 16

0 24

2

VITEK® 2 OPUS AST CARDSGiving clinicians more treatment options

What if you could use the same familiar workflow and instruments but test more antibiotics simultaneously?

Discover VITEK® 2 OPUS AST* CARDS: the expanded version of our trusted VITEK® 2 AST* CARDS.

• Test more antibiotics• Up to 34 relevant drugs per card• 60% increase in antibiotics

• Streamlined work� ow• Trusted VITEK® 2 protocols and instruments†• Less need for additional testing

• Save costs, increase e� ciency• Sta� can focus on what matters• Stock and use fewer types of cards

• Proven medical value• Help deliver the right drug at the right time• Report more targeted antibiotic choices up to

18 hours faster4,5

Innovation in microbiology must never stop – because your labchallenges never stop. For more than 50 years, bioMérieux hasshared your commitment to continually strengthen laboratoryimpact on patient therapy.VITEK® 2 OPUS AST cards are part of our integrated ID AST** o� er.Together with our blood culture o� er, it meets your needs fromthe most routine to the truly challenging. Our o� ers let you leverage your expertise to deliver test results that enable the healthcare team to provide timely, appropriate therapy.

bioMérieux S.A. • 69280 Marcy l’Étoile • France • Tel.: + 33 (0)4 78 87 20 00 • Fax: +33 (0)4 78 87 20 90www.biomerieux.com

Contact your bioMérieux representative for availability

* AST: antimicrobial susceptibility testing ** ID/AST: identi� cation and susceptibility testing† Minimum software and � rmware versions required

REFERENCES 1- Galar A., Yuste J.R., Espinosa M., Guillén-Grima F., Hernáez-Crespo S., and Leiva J. Clinical and economic impact

of rapid reporting of bacterial identi� cation and antimicrobial susceptibility results of the most frequently processed specimen types. Eur. J. Clin. Microbiol. Infect. Dis. 2012;31 (9):2445-2452

2- Galar A., Leiva J., Espinosa M., Guillén-Grima F., Hernáez S., Yuste JR. Clinical and economic evaluation of the impact of rapid microbiological diagnostic testing. J. of Infection 2012;65(4):302-309

3- Barenfanger J., Drake C., and Kacich G. Clinical and Financial Bene� ts of Rapid Bacterial Identi� cation and Antimicrobial Susceptibility Testing. J. Clin. Microbiol. 1999;37(5):1415-1418

4- Ayats J., et. al. ASM 2007; Poster C-158.5- Source: Simon-Kucher & Partners internal study

Now you can with the new VITEK® 2 OPUS AST cards. You will reduce the need for subsequent testing – and that minimizes delays in reporting. Give your clinicians crucial susceptibility information to help them optimize patient therapy sooner.1,2,3

VITEK® 2 OPUS AST CARDS

Gram-negative organisms

Same size card

More antibiotics